This data is in line with the unusual epitope specificity of anti-β2GPI antibodies documented in Figure 2, supporting the hypothesis that aPL found in COVID-19 patients are different from aPL found in APS patients. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.